TB-Related Articles

2022 DTBE Publications

Burzynski J, Mangan JM, Lam CK, Macaraig M, Salerno MM, deCastro BR, Goswami ND, Lin CY, Schluger NW, Vernon A; eDOT Study Team. In-Person vs Electronic Directly Observed Therapy for Tuberculosis Treatment Adherence: A Randomized Noninferiority Trial.external icon JAMA Netw Open. 2022 Jan 4;5(1):e2144210. doi: 10.1001/jamanetworkopen.2021.44210. PMID: 35050357; PMCID: PMC8777548.

Carr W, Kurbatova E, Starks A, Goswami N, Allen L, Winston C. Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis – United States, 2022.external icon MMWR Morb Mortal Wkly Rep. 2022 Feb 25;71(8):285-289. doi: 10.15585/mmwr.mm7108a1. PMID: 35202353.

Filardo TD, Feng PJ, Pratt RH, Price SF, Self JL. Tuberculosis – United States, 2021.external icon MMWR Morb Mortal Wkly Rep. 2022 Mar 25;71(12):441-446. doi: 10.15585/mmwr.mm7112a1. PMID: 35324877; PMCID: PMC8956339.

Ho CS, Feng PJ, Narita M, Stout JE, Chen M, Pascopella L, Garfein R, Reves R, Katz DJ; Tuberculosis Epidemiologic Studies Consortium. Discordant results of tests for tuberculosis reconsidered – Authors’ reply.external icon Lancet Infect Dis. 2022 Feb;22(2):164-165. doi: 10.1016/S1473-3099(21)00805-7. PMID: 35092787.

Holzman SB, Perry A, Saleeb P, Pyan A, Keh C, Salcedo K, Narita M, Ahmed A, Miller TL, Pettit AC, Khurana R, Whipple M, Katz D, Largen A, Krueger A, Shah M. Evaluation of the latent tuberculosis care cascade among public health clinics in the United States.external icon Clin Infect Dis. 2022 Apr 1:ciac248. doi: 10.1093/cid/ciac248. Epub ahead of print. PMID: 35363249.

Phares CR, Liu Y, Wang Z, Posey DL, Lee D, Jentes ES, Weinberg M, Mitchell T, Stauffer W, Self JL, Marano N. Disease Surveillance Among U.S.-Bound Immigrants and Refugees – Electronic Disease Notification System, United States, 2014-2019.external icon MMWR Surveill Summ. 2022 Jan 21;71(2):1-21. doi: 10.15585/mmwr.ss7102a1. PMID: 35051136; PMCID: PMC8791661.

Phillips PPJ, Kurbatova EV, Dorman SE. Four-Month Rifapentine Regimens for Tuberculosis. Reply.external icon N Engl J Med. 2022 Mar 17;386(11):1095-1096. doi: 10.1056/NEJMc2114483. PMID: 35294823.

Shrestha S, Winglee K, Hill A, Shaw T, Smith J, Kammerer JS, Silk BJ, Marks S, Dowdy D. Model-based analysis of tuberculosis genotype clusters in the United States reveals high degree of heterogeneity in transmission, and state-level differences across California, Florida, New York, and Texas.external icon Clin Infect Dis. 2022 Feb 10:ciac121. doi: 10.1093/cid/ciac121. Epub ahead of print. PMID: 35143641.

Smith JP, Modongo C, Moonan PK, Dima M, Matsiri O, Fane O, Click ES, Boyd R, Finlay A, Surie D, Tobias JL, Zetola NM, Oeltmann JE. Tuberculosis attributed to transmission within healthcare facilities, Botswana-The Kopanyo Study.external icon Infect Control Hosp Epidemiol. 2022 Apr 6:1-7. doi: 10.1017/ice.2021.517. Epub ahead of print. PMID: 35382909.

Tasneen R, Garcia A, Converse PJ, Zimmerman MD, Dartois V, Kurbatova E, Vernon AA, Carr W, Stout JE, Dooley KE, Nuermberger EL. Novel Regimens of Bedaquiline-Pyrazinamide Combined with Moxifloxacin, Rifabutin, Delamanid and/or OPC-167832 in Murine Tuberculosis Models.external icon Antimicrob Agents Chemother. 2022 Mar 22:e0239821. doi: 10.1128/aac.02398-21. Epub ahead of print. PMID: 35315690.

Wang Z, Posey DL, Brostrom RJ, Morris SB, Marano N, Phares CR. Post-Arrival Evaluation of Immigrant and Refugee Children in the USA with Latent Tuberculosis Infection Diagnosed Overseas, 2007‒2019.external icon J Pediatr. 2022 Feb 1:S0022-3476(22)00080-4. doi: 10.1016/j.jpeds.2022.01.049. Epub ahead of print. PMID: 35120982.

Winglee K, Hill AN, Belknap R, Stout JE, Ayers T. Variability of interferon-γ release assays in people at high risk of tuberculosis infection or progression to tuberculosis disease living in the United States.external icon Clin Microbiol Infect. 2022 Feb 17:S1198-743X(22)00094-5. doi: 10.1016/j.cmi.2022.02.020. Epub ahead of print. PMID: 35183749.

Winglee K, Hill AN, Langer AJ, Self JL. Decrease in Tuberculosis Cases during COVID-19 Pandemic as Reflected by Outpatient Pharmacy Data, United States, 2020.external icon Emerg Infect Dis. 2022 Apr;28(4):820-827. doi: 10.3201/eid2804.212014. PMID: 35318920; PMCID: PMC8962886.